Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$24.60
-5.89%
Mkt Cap $3.73B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
Implied Upside
+29.1%
Consensus $31.75 vs current $24.60
NYSE·Healthcare·Biotechnology
$24.60
-5.89%
Mkt Cap $3.73B
Buy
5
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
+29.1%
Consensus $31.75 vs current $24.60